Skip to main content
. 2018 Jun 14;24(22):2400–2405. doi: 10.3748/wjg.v24.i22.2400

Table 1.

Demographic and tumor characteristics for stage III pancreatic cancer patients n (%)

Characteristics Number of patients
T(1-3)N2 (n = 1526) T4N(0-1) (n = 138) T4N2 (n = 80)
Age
18-59 496 (32.5) 44 (31.9) 32 (40)
60-79 932 (61.1) 84 (60.9) 41 (51.2)
> 80 98 (6.4) 10 (7.2) 7 (8.8)
Race
White 1295 (84.8) 110 (79.7) 64 (80)
Black 131 (8.6) 16 (11.6) 7 (8.8)
Others 100 (6.6) 12 (8.7) 9 (11.2)
Sex
Male 809 (53.0) 72 (52.2) 39 (48.8)
Female 717 (47.0) 66 (47.8) 41 (51.2)
Grade
 I 125 (8.2) 17 (12.3) 10 (12.5)
II 691 (45.2) 63 (45.7) 32 (40)
III 627 (41.1) 42 (30.4) 29 (36.3)
IV 13 (0.9) 0 (0) 2 (2.5)
Unknown 70 (4.6) 16 (11.6) 7 (8.7)
Marital status
Single 504 (33.0) 43 (31.1) 29 (36.3)
Married 987 (64.7) 91 (66.0) 49 (61.2)
Unknown 35 (2.3) 4 (2.9) 2 (2.5)
Primary site
Head of pancreas 1266 (83.0) 87 (63.0) 62 (77.5)
Other parts of pancreas 260 (17.0) 51 (37.0) 18 (22.5)
Histology
Adenomas and adenocarcinomas 809 (53.0) 74 (53.6) 39 (48.8)
Ductal and lobular neoplasms 625 (41.0) 48 (34.8) 30 (37.5)
Others 92 (6.0) 16 (11.6) 11 (13.7)